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Synopsis: The extent of IOP rise after a 15-minute dark room prone provocative test 
failed to separate open angle from primary angle closure suspects. It also did not 
predict the risk of worsening over time. 
 
Abstract 
Purpose: To describe the results of dark room prone provocative testing (DRPPT) in 
primary angle closure suspects (PACS) and to compare the findings to controls with 
open angles.   
Methods: 889 subjects with PACS in the ZAP Trial (a randomized controlled trial to 
compare prophylactic laser iridotomy to no treatment in PACS) and 89 with open angles 
in the Liwan Eye Study 5-year follow up study were placed in a dark room face down for 
15 minutes. Intraocular pressure (IOP) was measured immediately before and after 
DRPPT. 
Results: PACS participants were of similar age than controls (59.3 versus 60.5), more 
often female (82.9 versus 58.4%), and had lower IOP (14.3 versus 15.2mmHg). The 
average IOP increase after DRPPT was 4.33mmHg in PACS and 5.22.8 in controls 
(p<0.05). 20.5% of controls and 13.9% of those with PACS developed an IOP spike 
8mmHg after DRPPT (p<0.05). Among PACS, 15.8% of those with all four quadrants 
closed had an IOP elevation of ≥8mmHg as opposed to 10.0-12.4% with two or three 
closed quadrants (p<0.05). DRPPT failed to predict who would reach a clinical trial 
endpoint over 6 years follow-up of those with PACS. 
Conclusions: A modified DRPPT failed to separate PACS from those with open angle. 
Although the test resulted in greater IOP elevation among those PACS participants with 
all four quadrants closed than in those with two or three closed quadrants, it did not 
offer any insight into the risk of developing acute or chronic angle-closure disease over 




Provocative testing in glaucoma was first proposed by Grönholm in 1910, who noted an 
increase in intraocular pressure (IOP) in 1 of 10 patients in dark conditions, and a 
reduction of IOP in the light.1 The author suggested that glaucoma could be identified in 
some cases by assessing IOP before and after sitting in the dark for several hours. The 
prone test was described in 1968 by Hyams et al2, who examined 208 patients who laid 
face down for one hour with the forehead resting on the back of the hands (to avoid 
pressure on the eyes), and found a positive result (IOP rise >/= 8mmHg) in 70% of 47 
eyes with known angle-closure glaucoma, 49% of 35 suspected angle closure glaucoma 
eyes, 7% 56 eyes with open angle glaucoma, and 4% of 70 normal eyes. Dark room 
and prone provocative testing were evaluated by Harris and Galin3 in 1972 and were 
both found to separate those with angle closure from those with open angles.  Although 
it has been in use for 5 decades, few studies have assessed how well the dark room 
prone provocative test (DRPPT) separates those with open angles from those with 
angle closure or whether or not it can help distinguish which persons with angle closure 
are more likely to develop problems over time.  While a report from China found that the 
number of closed angles on anterior segment OCT was predictive of an intraocular 
pressure (IOP) increase of 8 mmHg or more after the DRPPT among a group of 
subjects with limbal anterior chamber depth ≤ 25% of corneal thickness, only one study 
has prospectively assessed subjects after DRPPT.  In that study, the DRPPT was 
poorly predictive of who would develop acute or chronic angle closure.4  
Much of the early research on DRPPT studied mixed populations of angle closure 
patients including those who had experienced an acute attack in the past as well as 
those with angle closure alone or more severe angle closure glaucoma.  The results 
from those studies are difficult to apply to specific groups of patients and therefore 
clinicians lack guidance on whether or not to use the test and if so, how to interpret it.  
The present study was designed to assess how well a modified DRPPT (shortened to 
fifteen minutes from one hour) performed in a group of primary angle closure suspects 
(PACS), and compared the findings to those for persons with open angles. 
Methods 
Subjects with PACS were evaluated with a modified DRPPT as part of the qualification 
examination for the Zhongshan Angle Closure Prevention (ZAP) Trial (registered as 
‘ISRCTN45213099-Zhongshan Angle-closure Prevention Study’ [http://www.controlled-
trials.com/ISRCTN45213099]. Recruitment started in June 2008 and ended in October 
2010.5  Those with open angles were a consecutive group of subjects found to have 
open angles on gonioscopy who were participating in the five-year follow up of the 
Liwan Eye Study enrolled over a six-week period (89 of 874 total participants).  The 
Liwan Eye Study was a population-based cohort study of persons living in the same 
district of Guangzhou city as those with PACS aged 50 and above.6 In brief, 11,991 
residents living near the Zhongshan Ophthalmic Center (ZOC) participated in a 
screening evaluation and those with posterior (usually pigmented) trabecular meshwork 
not visible for 180 degrees or more on static gonioscopy without elevated IOP, 
peripheral anterior synechiae (PAS) or glaucoma were considered to have PACS and 
were asked to participate in the ZAP trial.  These persons made up the angle closure 
study participants in the current analysis. The ZAP Trial was approved in China by the 
Ethics Committee of ZOC, and also received institutional review board approval from 
Johns Hopkins and Moorfields Eye Hospital (via the London School of Hygiene and 
Tropical Medicine).   The open angle subjects in the present study were participants in the 
Liwan Eye Study who were being examined as part of a five-year follow up study and had 
open angles in all four quadrants on gonioscopy.  Recruitment occurred when time was 
available on four separate occasions with 20 subjects recruited each time. They were 
enrolled under a protocol approved by the ZOC ethics board.  
For the ZAP Trial, intraocular pressure at the screening examination was measured with 
non-contact tonometry (NCT, using a Topcon CT-80A (Tokyo, Japan)). Participants with 
NCT values greater than 24 mmHg in either eye underwent Goldmann applanation 
tonometry (GAT) to confirm IOP elevation. Participants with GAT above 21 mmHg were 
excluded. 
Gonioscopy: Gonioscopy was performed on all subjects by the same glaucoma-trained 
ophthalmologist (SH) who had high reliability when compared to glaucoma specialists 
with more than 10 years previous experience conducting angle closure research (MH, 
weighted kappa >0.80). Following topical anesthesia, static gonioscopy was performed 
using a one mirror Goldmann-type gonioscopy lens (Single Mirror Gonioscope, Ocular 
Instruments, Bellevue, WA, USA) with low ambient illumination and a narrow, 1 mm 
long beam. Care was taken to avoid the beam falling on the pupil in order to prevent 
alteration of the angle configuration. If trabecular meshwork could not be seen because 
of marked iris convexity, slight tilting of the gonioscope was allowed to achieve an “over 
the hill” view by tilting the lens towards the trabecular meshwork (TM). Excessive tilting 
which might cause inadvertent corneal indentation was avoided. A dynamic examination 
was carried out by increasing the length and width of the beam, as well as increasing 
brightness. The examinee was asked to look directly towards the mirror of the 
gonioscope, bringing the adjacent rim of the gonioscope over the central cornea. 
Pressure was exerted on the rim of the gonioscope in order to indent the central cornea. 
If iridotrabecular contact was not satisfactorily reversed, a dynamic examination with a 
4-mirror gonioscope (Ocular Sussman Four Mirror Gonioscope, Ocular Instruments, 
Washington, USA) was carried out to determine if PAS were present. PAS were defined 
as acquired adhesions of the iris to the corneo-scleral wall crossing the scleral spur for 
a width of 1 clock hour or more resulting in tenting of the peripheral iris. Those with PAS 
were excluded from the trial as were those with elevated IOP as noted above. 
Participants with pigmented trabecular meshwork (PTM) not visible in at least two 
quadrants on gonioscopy (without PAS) in both eyes were diagnosed as PAC suspects 
(PACS) and considered eligible for the ZAP trial, and had repeat gonioscopy by a 
second glaucoma-trained ophthalmologist (YJ) to confirm the findings. Those with open 
angles did not undergo repeat gonioscopy 
Ocular Biometry by A-Scan  
Axial length, anterior chamber depth and lens thickness were measured using a 10 MHz 
A-mode ultrasound device (Nidek US1800) using a hard-tipped, corneal contact probe 
mounted on a Haag-Streit tonometer set to the intraocular pressure.  The mean of 16 
separate readings were recorded, together with standard deviation of each parameter.  
If the standard deviation for axial length measurement was ≥ 0.13 mm was, the reading 
was repeated up to another two times.  None of the final readings had and SD ≥ 0.13 
mm. 
Cataract grading 
All subjects underwent cataract grading using the Lens Opacity Classification System III 
(LOCS III) for nuclear color (NC), nuclear opalescence (NO), cortical (C) and posterior 
subcapsular cataract (PSC) at the slit lamp after pharmacologic dilation of the pupil and 
standard photographs were available for reference during the evaluation.7 Grading was 
carried out by 3 trained graders who underwent an initial period of standardization and 
additional training sessions by one senior glaucoma specialist over the course of the 
study. 
Limbal anterior chamber depth 
The limbal anterior chamber depth (LACD) was evaluated by a modified van Herick 
grading system using a slit lamp (BQ-900, Haag-Streit, Switzerland). LACD was graded 
clinically, with reference to standard photographs, as the depth of the temporal anterior 
chamber at the corneoscleral junction, expressed as a percent of the adjacent corneal 
thickness.8  
Modified Dark Room Prone Provocative Testing (DRPPT):  
A modified DRPPT was performed on both the PAC suspects and those with open 
angles. Following topical anesthesia and a baseline IOP measurement using a Tonopen 
applanation tonometer (TonoPen XL, Medtronic, Florida, USA), the subject lay face-
down on a padded table in a dark room for 15 minutes with the forehead resting on a 
soft pillow. The subject was accompanied by a research nurse and allowed to talk so as 
not to fall asleep. A second IOP measurement using the same method was performed 
after 15 minutes. The measurement was made within 30 seconds of moving from face-
down position to upright in a lighted environment.  
Statistical Analysis 
Data of both right and left eyes were included in the analyses. Baseline characteristics 
and ocular biometrics were compared between open angle and PACS groups using t-
test with unequal variance for continuous variables, and Chi-Square tests for 
dichotomous variables. The association between angle closure status and IOP elevation 
after DRPPT was evaluated using multi-level modeling taking into account the 
correlation between the two eyes. Smoothed scatter plots (Lowess function) were used 
to examine the assumption of a linear relationship between the average Shaffer score 
and IOP change after DRPPT. Boxplots were used to examine the distribution of the 
IOP change after DRPPT by quadrants of angle closure in PACS. 
Among subjects with PACS, differences between the 3 groups (defined by 2, 3, and 4 
quadrants of angle closure) were analyzed using analysis of variance (ANOVA). 
Multilevel logistic regression analysis was performed to assess for factors associated 
with an IOP elevation of 5 mmHg or 8 mmHg or more after DRPPT. As subjects with 
PACS were part of a 72-month randomized controlled trial, we also assessed whether 
DRPPT predicted the development of trial endpoints (elevation of intraocular pressure, 
or peripheral anterior synechiae, or acute angle closure) over 6 years.5  All analyses 
were performed using Stata/SE, 13.1 (StataCorp, College Station, TX). 
Results 
889 primary angle closure suspects (PACS) and 89 individuals from the Liwan Eye 
Study with open angles underwent DRPPT (all were Chinese residents of Guangzhou). 
PACS participants were slightly younger than open angle controls (59.3 versus 60.5) 
were more often female (82.9% versus 58.4%), and had lower IOP at baseline (14.3 
versus 15.2, p < 0.05 for all, Table 1, Figure 1). Furthermore, subjects with PACS had 
narrower angles on gonioscopy, shorter axial lengths, thicker lenses, shallower anterior 
chamber depths and denser cataracts (p < 0.05 for all).   
The average IOP increase after DRPPT was 4.3 mmHg (SD = 3.0) in PACS and 5.2 
(SD = 2.8) in those with open angles (p < 0.05, Figure 2 and Table 2). 61.0% of those 
with open angles and 46.1% of those with PACS developed an IOP elevation of 5 
mmHg or more after DRPPT (p < 0.05 for the difference in proportion).  A similarly 
higher proportion of those with open angles developed an IOP spike of 8 mmHg or more 
(20.5% versus 13.9%, p < 0.05). A threshold effect was not found in quadrants of angle 
closure and IOP change (Figure 3). 
Among PACS, those with all four quadrants closed had a greater IOP increase 
(Figure,3-4, Table 3) than those with two or three quadrants of angle closure (Table 3).  
Of those with all four quadrants closed, 15.8% had an IOP elevation of ≥ 8 mmHg as 
opposed to 10.0-12.4% with two or three closed quadrants (p < 0.05). In univariate 
analysis, people with all four quadrants closed had a 1.6 times higher odds of 
developing an IOP elevation of 8 mmHg or more after DRPPT compared with people 
with 2 or 3 quadrants closed (Table 4). This association remained statistically significant 
after adjusting for age, gender and baseline IOP. Lower baseline IOP and narrower 
angle (measured by average Shaffer score) were also associated higher odds of 
developing an 8mmHg IOP elevation. Other factors such as age, gender, central ACD, 
axial length and lens thickness were not associated with an IOP elevation ≥ 8mmHg. 
For PACS eyes that did not receive any intervention (control arm in the ZAP trial), IOP 
change after DRPPT was not a predictor for angle closure progression in 72 months 
(Table 5).  
 
 Discussion 
In this study, people with open angles were more likely to have a significant pressure 
rise than those with partially or fully occluded angles during a modified DRPPT. 
Although the test resulted in greater IOP elevation in those classified PACS in whom all 
four quadrants were closed compared with those with two or three closed quadrants, 
the results of this trial where one eye was left untreated for 72 months showed that 
baseline DRPPT did not predict who would go on to develop PAS, elevated IOP or an 
acute attack.  
The DRPPT was first recommended over 40 years ago by Harris who found that those 
with closed angles were far more likely to have elevation in IOP than those with open 
angles.3 Authors at that time applied the DRPPT to a mix of persons with varying 
amounts of angle closure (including some who had previously had an acute attack) and 
assumed that an increase in IOP was a sign of a predisposition to angle closure 
glaucoma.   The test was performed for one hour.  While the DRPPT on average 
causes IOP elevation, it is clear from the present study that this finding is not unique to 
persons with angle closure.  
The rationale for evaluating angle closure subjects in the dark is based on a large body 
of data that show that angles are more likely to close in dim illumination.   Many who are 
open on gonioscopy in bright light will be closed when viewed in the dark.  Pavlin 
described a dark room provocative test using UBM in eight patients who were identified 
as having irido-trabecular contact in response to decreased illumination.9  A high 
likelihood of appositional closure in the dark was also reported in a population of 
Japanese subjects with either suspect PAC, PAC, PACG or fellow eyes of persons 
undergoing an acute attack of angle closure.10  Similar findings were documented in the 
fellow eyes of Singapore Chinese subjects.11  Furthermore, we previously reported that 
the fellow eyes of persons with unilateral acute attacks have more substantial angle 
narrowing in the dark than normal controls.11 
Placing persons face down theoretically should lead to anterior movement of the lens 
iris diaphragm.  This could cause further closure of the angle and lead to an elevation of 
IOP.  The combination of darkness and prone positioning clearly leads to IOP elevation, 
but elevation occurred in those with open angles as well as those with angle closure.  
The current study demonstrates that using the shortened DRPPT that was studied in 
this trial does not help separate these two groups.  While previous researchers had 
performed DRPPT for one hour, we believed that if the test were found to have 
predictive value it would be much more likely to be used clinically if it were shorter.  We 
therefore reduced the time to 15 minutes assuming that it would be adequate time to 
allow for movement of the lens iris diaphragm and increase in IOP. This modified 
DRPPT also was not useful in predicting which PACS subjects were at highest risk for 
progressing to primary angle closure or acute angle closure.  The only prospective 
study that previously assessed this question followed 129 subjects at multiple centers 
for an average of 2.7 years.  Eight patients (6 %) developed acute angle closure attacks 
in the follow-up period, while another 17 patients (13%) developed primary angle 
closure, defined as appositional or synechial closure of 0.5 to 3 clock hours in the 
superior angle.4 The DRPPT was unable to accurately predict those patients who went 
on to angle closure.  To our knowledge, the present study is the largest prospective 
cohort evaluating a DRPPT and again found that it failed to predict who would progress 
to angle closure disease or develop acute angle closure over 6 years. 
Certain factors predisposed to a larger increase in IOP after the DRPPT.  The finding 
that people with lower IOP had a larger increase in IOP after DRPPT is likely due in part 
to regression to the mean since the IOP fluctuates naturally and those with lower IOP 
would have been more likely to have a higher IOP on repeat testing and those with 
higher IOP would have been more likely to have a lower IOP on repeat testing. 
It is unclear why those with open angles had a larger increase in IOP in response to this 
shortened DRPPT than those with PACS.  It is possible that the trabecular meshwork is 
compacted with slight anterior lens diaphragm movement, even in open angles, 
reducing aqueous outflow.  We did not measure the change in the position of the lens 
after prone positioning in the present study, but it is possible that this could be assessed 
with anterior segment OCT in the future.  In unpublished data we previously found that 
there were no changes in anterior chamber depth in response to supine positioning 
when compared to anterior chamber depth measured when seated.  Perhaps there are 
hydrostatic changes that occur with prone head posture since the head is no longer 
above the heart?  This could in theory raise episcleral venous pressure and lead to 
increased IOP via this mechanism.  Alternatively, the choroid may expand leading to a 
transient increase in IOP.  Additional research will be required to determine the 
mechanism of IOP elevation and why IOP elevation was greater for those with open 
angles. However, if we only look at the degree of angle closure among those with 
PACS, we found eyes with narrower angle were more likely to develop an 8mmHg IOP 
elevation after DRPPT.  It is possible that our exclusion of those with angle closure and 
high IOP may have limited our ability to see a difference in DRPPT across the spectrum 
of angle closure.   
This study was community based and may not represent cases that come to the clinic.  
In addition, angle closure mechanisms may vary across populations and the findings 
from this Chinese population may not apply to others.  Furthermore, we only assessed 
PACS subjects and the results for those with PAC or PACG may in fact be different. 
Finally, the DRPPT used was 15 minutes, shorter than in some previous reports, and 
this may have reduced the effectiveness of the test. We elected to use a 15-minute test 
for two reasons.  First, it is clinically impractical to do the DRPPT for one hour.  The long 
duration of the test requires full-time accompaniment to avoid the patient falling asleep, 
and the one-hour test is rarely used in clinical practice.  Second, our previous work 
looking at anterior segment changes in response to illumination indicates that it these 
changes occur nearly instantaneously.12  We did not believe that longer prone 
positioning would dramatically affect the results.  Additional studies are required to 
confirm these assumptions. 
In conclusion, the DRPPT did not distinguish those PACS subjects from those with open 
angles in this large study of Chinese individuals. The extent of IOP rise after DRPPT 
also failed to predict later outcomes. 
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Age (yrs, mean SD) 59.30 5.01 60.49 3.54   0.005 






Baseline IOP (mmHg, mean SD) 14.32 2.62 15.17 3.08 <0.001 
Central ACD (mm, mean SD)   2.55 0.22   2.86 0.31 <0.001 
Axial length (mm, mean SD)* 22.49 0.73 23.50 1.04 <0.001 
Lens thickness (mm, mean SD)*   4.88 0.32   4.77 0.38 0.011 
Cataract grading (mean SD)** 
   Nuclear opalescence 
   Nuclear color 
   Cortical 
















Limbal anterior chamber depth (% corneal 
thickness) *** 
22.16 7.62 53.84 26.00 <0.001 
Average Shaffer score (mean SD)+   1.33 0.60   3.46 0.61 <0.001 
Number of Quadrant Closed (mean SD)+   3.55 0.66   0.15 0.41 <0.001 
 
Abbreviation: PACS, primary angle closure suspects; SD, standard deviation; N, number of 
persons; n, number of eyes. 
*Measured by A-Scan with SD0.13 
** Graded using the Lens Opacity Classification System III  
***Graded by van Herick 
+Graded by gonioscopy 
 
Table 2. Intraocular Pressure Change After Dark Room Prone Provocative Test by Primary 







IOP change(mmHg, mean SD) 4.25 2.99  5.23 2.77 <0.001* 
IOP increase≥5mmHg (%) 46.06% 60.80% <0.001 
IOP increase≥8mmHg (%) 13.89% 20.45% 0.018 
% of IOP increase (%, mean SD) 32.1 24.6 37.3 23.4 0.006 
IOP increase≥20% baseline (%) 67.77% 77.27% 0.010 
IOP increase≥40% baseline (%) 34.93% 40.34% 0.152 
IOP increase≥60% baseline (%) 13.27% 15.91% 0.329 
 
Abbreviation: PACS, primary angle closure suspects; IOP, intraocular pressure; SD, standard 
deviation. 
*Adjusted for baseline IOP 
 
Table 3. Intraocular Pressure Change After Dark Room Prone Provocative Test and Quadrants 
of Angle Closure among Primary Angle Closure Suspects 












IOP change(mmHg, mean SD) * 4.23 2.85 4.14 2.89 4.30 3.05 0.625 
IOP change≥5mmHg (%) 46.3 46.4 45.9 0.984 
IOP change≥8mmHg  (%) 12.4 10.0 15.8 0.007 
% of IOP increase (%, mean SD)* 33.8 26.6 32.0 23.8 32.0 24.6 0.661 
IOP increase≥20% baseline  (%) 69.1 70.1 66.6 0.368 
IOP increase≥40% baseline  (%) 38.3 36.6 33.7 0.353 
IOP increase≥60% baseline  (%) 16.7 10.6 13.9 0.082 
Table 4. Predictors for Intraocular Pressure Rise ≥ 8mmHg after Dark Room Prone Provocative 
Test in Primary Angle Closure Suspects 








Age (10 years older) 0.93 (0.71-1.21) 0.583 0.85 (0.64-1.13) 0.260 
Female 0.81 (0.57-1.13) 0.218 0.80 (0.56-1.14) 0.212 
Baseline IOP (mmHg) 0.78 (0.74-0.83) <0.001 0.78 (0.74-0.83) <0.001 
Quadrants of angle closure 









Average Shaffer score 0.65 (0.52-0.81) <0.001 0.58 (0.46-0.72) <0.001 
Central ACD (mm) 0.68 (0.37-1.25) 0.213 0.90 (0.47-1.71) 0.746 
Axial Length (mm) 1.13 (0.94-1.35) 0.209 1.19 (0.99-1.44) 0.069 
Lens thickness (mm) 1.14 (0.75-1.74) 0.544 1.20 (0.76-1.89) 0.429 
 
Abbreviation: IOP, intraocular pressure; ACD, anterior chamber depth 
*Adjusted for age, gender and baseline IOP 
 
Table 5. The Association Between Dark Room Prone Provocative Tests and Incidence of Angle 
Closure in 72 Months Among Primary Angle Closure Suspects 
 
 Hazard ratio (95% CI) p-value 
Univariate:   
  DRPPT IOP increase (mmHg) 1.00 (0.90-1.12) 0.792 
Multivariate:   
  DRPPT IOP increase (mmHg) 1.00 (0.89-1.12) 0.967 
  Baseline IOP (mmHg) 1.07 (0.96-1.20) 0.230 
  Age (per year increase) 1.06 (0.99-1.13) 0.079 
  Female 1.11 (0.45-2.74) 0.451 
  Shaffer score 0.91 (0.79-1.04) 0.792 
 




Figure 1. Distribution of Change in Intraocular Pressure after Dark Room Prone Provocative 






Figure 2. Intraocular Pressure Change After Dark Room Prone Provocative Test and Baseline 
Intraocular Pressure  
 
 
Figure 3. Distribution of Change in Intraocular Pressure after Dark Room Prone Provocative 
Test by Quadrants of angle closure in PACS 
 
  
Figure 4. Lowess IOP Change after DRPPT over average Shaffer score in PACS 
 
 
 
